Quick answers
- What is Zenzedi?
- Zenzedi is a brand name of Dextroamphetamine, a prescription medicine. The FDA NDC Directory lists 7 Zenzedi products in 7 strengths and forms.
- Who makes Zenzedi?
- Azurity holds the FDA application for Zenzedi (ANDA090533, approved October 25, 2011).
- Is there a generic or store brand of Zenzedi?
- Yes. The FDA NDC Directory lists 35 other products with the same active ingredients, strength and form as a Zenzedi product, 35 of them generic. Ask your pharmacist whether one is right for you.
- What do pharmacies pay for Zenzedi?
- CMS lists a National Average Drug Acquisition Cost (NADAC) for 1 Zenzedi strength and form (see the table below). That is what pharmacies pay to buy it, not what you pay: your price depends on your insurance and your pharmacy.
- Has Zenzedi been recalled?
- FDA enforcement reports list 1 recall of Zenzedi products; the newest started January 4, 2024. A recall usually concerns specific lots, not every product.
What Zenzedi is
Each Zenzedi product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Dextroamphetamine · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| dextroamphetamine sulfate 10 mg tablet (oral) | Zenzedi | 12 products, 10 companies | DailyMed |
| dextroamphetamine sulfate 15 mg tablet (oral) | Zenzedi | 3 products, 3 companies | DailyMed |
| dextroamphetamine sulfate 2.5 mg tablet (oral) | Zenzedi | 1 product, 1 company | DailyMed |
| dextroamphetamine sulfate 20 mg tablet (oral) | Zenzedi | 3 products, 3 companies | DailyMed |
| dextroamphetamine sulfate 30 mg tablet (oral) | Zenzedi | 3 products, 3 companies | DailyMed |
| dextroamphetamine sulfate 5 mg tablet (oral) | Zenzedi | 12 products, 10 companies | DailyMed |
| dextroamphetamine sulfate 7.5 mg tablet (oral) | Zenzedi | 1 product, 1 company | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Dextroamphetamine →
FDA approval
- ANDA: Abbreviated New Drug Application: how a generic version is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| ANDA090533 | Azurity | October 25, 2011 | 7 |
What pharmacies pay (NADAC)
The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.
This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.
| Strength and form | Generic or brand | Pharmacies pay |
|---|---|---|
| dextroamphetamine sulfate 30 mg tablet | Brand: Zenzedi | $10.40 per tablet Generic of the same strength and form: $5.48 per tablet |
NADAC list of November 4, 2026; these prices took effect on April 22, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.
Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →
Companies that list Zenzedi
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Zenzedi products.
- Azurity Pharmaceuticals, Inc.7 products
Recalls
From FDA enforcement reports, matched by the product’s NDC code or label. A recall usually covers specific lots: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.
-
January 4, 2024 · Class I · Terminated · D-0323-2024
Labeling: Label Mix-up
Zenzedi (Dextroamphetamine Sulfate) CII Tablets, USP, 30 mg, 30-count bottle, Rx only, Mfd. for: Arbor Pharmaceuticals, LLC., Atlanta, Georgia, 30328, NDC 24338-856-03 — Azurity Pharmaceuticals, Inc.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.